NCT02435927 2021-04-28
ASLAN001 in Combination With Oxaliplatin and Capecitabine or Oxaliplatin and 5-FU With Leucovorin
National Cancer Centre, Singapore
Phase 1 Unknown
National Cancer Centre, Singapore
Benaroya Research Institute
Shanghai JMT-Bio Inc.
SuZhou Stainwei Biotech Inc.
Jiangsu Simcere Pharmaceutical Co., Ltd.